tiprankstipranks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market
1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
RESEARCH TOOLSreports
Want to see HK:1541 full AI Analyst Report?

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Balance Sheet

3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Balance Sheet

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total assets for Q4 2025 were ¥1.10B, an increase of 42.48% from the previous quarter. HK:1541 total liabilities were ¥308.40M for the fiscal quarter, a 29.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
¥ 1.10B¥ 922.00M¥ 874.59M¥ 839.98M¥ 892.84M
Total Liabilities
¥ 308.40M¥ 243.69M¥ 126.30M¥ 60.76M¥ 2.49B
Total Equity Gross Minority
¥ 790.47M¥ 678.30M¥ 748.29M¥ 779.22M¥ -1.60B
Other Metrics
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Debt to Assets